A Prospective Biomarker Study in Active Secondary Progressive Multiple Sclerosis (SPMS)Subjects Treated With Cladribine Tablets
Latest Information Update: 14 Jan 2022
At a glance
- Drugs Cladribine (Primary)
- Indications Multiple sclerosis
- Focus Biomarker; Pharmacodynamics; Therapeutic Use
- 17 Sep 2020 New trial record
- 16 Sep 2020 Status changed from not yet recruiting to recruiting.